Course Tag: CME
#90 Webinar – April 2022
In this session, Dr. Anderson will discuss how the evolution of cancer patient assessment has evolved in the past 30 years. How to look at the big picture of the patient case as well as the detail and how knowing what “phase” the cancer is in can help the clinician appropriately focus time and resources.
#87 COVID and the Nervous System
COVID and the Nervous System
#86 GI Cancer and Microbiome Considerations
We will discuss GI specific microbiome and cancer connections as well as specific cancer therapies. In this session Dr. Anderson will relate his experience and his review of the current data regarding the approach to GI cancers and their relationship to the microbiome. GI specific therapies and implementation will be discussed.
#85 Laboratory Medicine Series Part-6:
Laboratory medicine is a cornerstone of proper diagnosis and patient safety. This series is designed tobreak down the commonly used laboratory investigations in naturopathic and functional medicine.It will describe the tests in each category, discuss their meaning and define next steps to followwhen abnormalities are found.
#84 Laboratory Medicine Series Part-5 Hematology (Assessment Part-12)
Laboratory medicine is a cornerstone of proper diagnosis and patient safety. This series is designed to break down the commonly used laboratory investigations in naturopathic and functional medicine.It will describe the tests in each category, discuss their meaning and define next steps to follow when abnormalities are found.
#82 Laboratory Medicine Series Part-4 (Assessment Part-10)
Laboratory medicine is a cornerstone of proper diagnosis and patient safety. This series is designed to break down the commonly used laboratory investigations in naturopathic and functional medicine. It will describe the tests in each category, discuss their meaning and define next steps to follow when abnormalities are found.
#81 Lab Assessment Part-3 GI Lab Considerations
Laboratory medicine is a cornerstone of proper diagnosis and patient safety. This series is designed to break down the commonly used laboratory investigations in naturopathic and functional medicine. It will describe the tests in each category, discuss their meaning and define next steps to follow when abnormalities are found.
#80 Laboratory Assessment Part-2
In this webinar DrA will continue the lab assessment topics requested by subscribers. Our focus for this webinar will be pancreatic assessment, blood sugar assessment and “metabolic markers”.
#79 Laboratory Medicine Series: Part-1
Laboratory medicine is a cornerstone of proper diagnosis and patient safety. This series is designed to break down the commonly used laboratory investigations in naturopathic and functional medicine. It will describe the tests in each category, discuss their meaning and define next steps to follow when abnormalities are found.
#78 LDN Updates and Dosing Information
Since the publication of the data regarding cyclic dosing from St. George’s University by Liu, et. al in 2016 the question of continuous dosing of LDN versus cyclic dosing has been posed. In this presentation Dr. Anderson will discuss the cell and tumor biology – pharmacology interface where this idea comes from and develop the …
#77 Cases in Neurochemistry
Neurochemistry is accessed daily in medicine by commonly used neuropsychiatric drug classes. In natural and integrative medicine, it is often confusing where to start with cases involving neurotransmitters and other factors due to overlap of signs and symptoms, concomitant medication use, and other issues. In this webinar Dr. Anderson will use his experience in thousands …
#76 Blood-Brain and GI Barrier Connection:
The barrier functions of the GI tract and the Brain were long thought to be separate. Modern research has not only shown a connection but an interdependence between these two critical systems. This presentation will look at the recent science showing these connections and discuss the clinical importance of repair of the systems in the …
#75 Immunology Part 5 Functional Immunology and Updates on TH1/2/17 Balance
Immunology is an ever-emerging part of biomedical science. In this session Dr. Anderson will update attendees regarding the Cell Mediated immune response, specifically where it concerns TH-1 and TH-2 effects, and their related immunology. The interrelationships between this portion of CMI and clinical medicine will be discussed.
#74 PharmPart-23 Vitamin C Use: Pharmacology, Safety, & Clinical Tips Q&A Part 2
The use of Vitamin C in integrative and Naturopathic medicine has a long history. The increase in use of newer forms such as liposomal oral products and wider use of IV Vitamin C has sparked a new group of clinical questions, safety and administration guidelines and general mechanism conundrums. This second installment CE is a …
#74 PharmPart-23 Vitamin C Use: Pharmacology, Safety, & Clinical Tips Q&A Part 2 Read More »
#73 Vitamin-C: Clinical Q&A Part-1
The use of Vitamin C in integrative and Naturopathic medicine has a long history. The increase in use of newer forms such as liposomal oral products and wider use of IV Vitamin C has sparked a new group of clinical questions, safety and administration guidelines and general mechanism conundrums. This CE is a merger of …
#72 – Biological Medicines
#72 – Biological Medicines: Clinical Tips, Considerations, and Integrations with natural medicines. Targeted biological therapies have in one way revolutionized some chronic GI diseases. In other ways they have complicated the landscape, monitoring and management of the GI patient. The positive and negative aspects of these therapies will be discussed. Common drugs, adverse events and …
#71 Post COVID Syndrome
2.0 Hours Total / 1.0 Hours Pharmacology #71 Post COVID Syndrome Post-COVID syndrome affects a portion of patients who have had COVID-19. The random nature of the signs and symptoms and their intensity are perplexing to clinicians trying to help these patients. In this CME Dr. Anderson will break down data from over 1000 patients …
#70 Toxins, Immune Function, and Cancer
#70 Toxins, Immune Function, and Cancer Outline: Risk factors for cancer and proposed mechanisms: Metal toxins Chemical toxins Mycotoxins Testing and assessment: Therapeutic Strategies: In the preventive setting In the “secondary prevention” setting treating after cancer care to prevent recurrence Got a question? Head to the forum! Every Webinar has an associated, private forum. If …
#69 Injection Update IM and SQ
#69 Injection Update IM and SQ In this session Dr. Anderson will use his many decades injection experience to discuss customizing parenteral nutrient combinations and specific dosages for maximum efficacy. While this presentation will cover the pharmacology and administration of Vitamin, Mineral and Amino Acids it may also include appropriate drug agents. IV and IM …
#61 Assessment Part-5 Red Flags and Critical Diagnosis Management
#61 Assessment Part-5 Red Flags and Critical Diagnosis Management In both the chronic and acute care setting the presentation of concerning clinical signs and symptoms can create a diagnostic and management quandary. If ongoing the presentation may simply need to be watched and monitored, if new or exacerbated the presentation may require acute work up …
#61 Assessment Part-5 Red Flags and Critical Diagnosis Management Read More »
#62 COVID-19 Part-1 Clinician Updates
#62 COVID-19 Part-1 Clinician Updates With the urgent and changing landscape off the COVID-19 Pandemic several urgent needs arise for healthcare providers in the area of patient management. While this CE is NOT meant to re-hash the “known” factors such as social isolation, quarantine, hand washing etc. it IS designed to look at potential needs …
#63 Assessment Part-6 Managing Comorbidity in Chronic Cases
#63 Assessment Part-6 Managing Comorbidity in Chronic Cases The chronically ill patient is difficult to manage considering their primary concerns regardless of cause. And while they often have infectious, hormonal, GI, toxic or many other underlying conditions to manage it is often the “transitory symptoms” that create the biggest clinical management troubles. In this webinar …
#63 Assessment Part-6 Managing Comorbidity in Chronic Cases Read More »
#64 PHARM Part-20 Repurposed Drugs in Oncology
#64 PHARM Part-20 Repurposed Drugs in Oncology Antibiotics, Anti-parasite and other drugs in cancer care? These seem to be making a lot of waves in oncology these days. Dr. Anderson will outline the data for and use of the primary off-label drug strategies as well as his experience with them. He will also look at …